Clinical trials
Completed Asthma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3,071 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 29 |
| 2001 | 36 |
| 2002 | 66 |
| 2003 | 84 |
| 2004 | 97 |
| 2005 | 131 |
| 2006 | 136 |
| 2007 | 173 |
| 2008 | 149 |
| 2009 | 171 |
| 2010 | 179 |
| 2011 | 168 |
| 2012 | 192 |
| 2013 | 128 |
| 2014 | 127 |
| 2015 | 153 |
| 2016 | 138 |
| 2017 | 145 |
| 2018 | 107 |
| 2019 | 114 |
| 2020 | 74 |
| 2021 | 104 |
| 2022 | 89 |
| 2023 | 63 |
| 2024 | 55 |
| 2025 | 37 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3,071 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 273 |
| GlaxoSmithKline | 231 |
| National Heart, Lung, and Blood Institute (NHLBI) | 71 |
| Organon and Co | 56 |
| Chiesi Farmaceutici S.p.A. | 54 |
| Boehringer Ingelheim | 53 |
| Novartis Pharmaceuticals | 50 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 38 |
| Sanofi | 31 |
| Imperial College London | 30 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 3,071 |
| Pulmonary Disease, Chronic Obstructive | 262 |
| Lung Diseases | 120 |
| Hypersensitivity | 118 |
| Rhinitis, Allergic | 77 |
| Obesity | 61 |
| Inflammation | 52 |
| Respiratory Sounds | 44 |
| Heart Failure | 42 |
| Lung Diseases, Obstructive | 42 |
Trials
Showing 1 to 25 of 3,071. Each trial links to its page on Pharma Observatory.
2,971 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.